P. Eldi

Receptor Co‑targeting Strategies for Personalized Ovarian Cancer Therapy

Abstract Ovarian cancer remains highly lethal due to late diagnosis, frequent recurrence, and rapid development of resistance to platinum-based chemotherapy. Although rational drug combinations targeting multiple oncogenic pathways hold promise, their clinical utility is often compromised by dose-limiting toxicity and...